Form 4: Alignment Healthcare CEO John Kao Sells 90,000 Shares

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock on September 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• John Kao, the CEO of Alignment Healthcare, sold 90,000 shares of common stock on September 16, 2024.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2024.
• The shares were sold at a weighted-average price of $11.6986, with individual prices ranging from $11.43 to $12.06.
• Following the transaction, Mr. Kao directly owns 2,745,253 shares and indirectly owns 2,633,100 shares through the JEK Trust, dated February 8, 2021, of which he is the trustee.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged plan. It doesn't inherently indicate positive or negative prospects for the company.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates this concern.

Key Dates